Paper24758331
Targeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance.
Szakács G and 7 others. Chem Rev, 2014. Cited by 174 papers, by iCite.
Cite this record
ConductScience Library. Targeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance. Papers, record 24758331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24758331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Resistance, Multiple | Major topic |
| Molecular Targeted Therapy | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Neoplasm Proteins |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| Intramural NIH HHS | United States | PubMed | PubMed | ||
| ZIABC005598 | NIH | NIH RePORTER | |||
| ZIABC010830 | NIH | NIH RePORTER |
References180
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15834856 | Anticancer multidrug resistance mediated by MRP1: recent advances in the discovery of reversal agents. | Med Res Rev | 2005 | https://conductscience.org/library/papers/15834856 | PubMed |
| 2 | 11417480 | Treatment with inhibitors of caspases, that are substrates of drug transporters, selectively permits chemotherapy-induced apoptosis in multidrug-resistant cells but protects normal cells. | Leukemia | 2001 | https://conductscience.org/library/papers/11417480 | PubMed |
| 3 | 12237881 | Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material. | J Pathol | 2002 | https://conductscience.org/library/papers/12237881 | PubMed |
| 4 | 19772851 | P-glycoprotein (ABCB1) modulates collateral sensitivity of a multidrug resistant cell line to verapamil. | Arch Biochem Biophys | 2009 | https://conductscience.org/library/papers/19772851 | PubMed |
| 5 | 19583429 | ABC efflux pump-based resistance to chemotherapy drugs. | Chem Rev | 2009 | https://conductscience.org/library/papers/19583429 | PubMed |
| 6 | 17088435 | Spotlight on molecular profiling: "Integromic" analysis of the NCI-60 cancer cell lines. | Mol Cancer Ther | 2006 | https://conductscience.org/library/papers/17088435 | PubMed |
| 7 | 9713496 | Parallel functional and immunological detection of human multidrug resistance proteins, P-glycoprotein and MRP1. | Anticancer Res | 1998 | https://conductscience.org/library/papers/9713496 | PubMed |
| 8 | 11747344 | Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion. | Br J Cancer | 2001 | https://conductscience.org/library/papers/11747344 | PubMed |
| 9 | 17345086 | Flavonoids inhibit breast cancer resistance protein-mediated drug resistance: transporter specificity and structure-activity relationship. | Cancer Chemother Pharmacol | 2007 | https://conductscience.org/library/papers/17345086 | PubMed |
| 10 | 20691599 | Iodination of verapamil for a stronger induction of death, through GSH efflux, of cancer cells overexpressing MRP1. | Bioorg Med Chem | 2010 | https://conductscience.org/library/papers/20691599 | PubMed |
| 11 | 2860971 | Cross-resistance of vinblastine- and taxol-resistant mutants of Chinese hamster ovary cells to other anticancer drugs. | Cancer Treat Rep | 1985 | https://conductscience.org/library/papers/2860971 | PubMed |
| 12 | 15913998 | Total synthesis and bioactivity of unique flavone desmosdumotin B and its analogs. | Bioorg Med Chem Lett | 2005 | https://conductscience.org/library/papers/15913998 | PubMed |
| 13 | 22724067 | Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what? | Open Biol | 2012 | https://conductscience.org/library/papers/22724067 | PubMed |
| 14 | 21634011 | Identification of xanthones as selective killers of cancer cells overexpressing the ABC transporter MRP1. | ChemMedChem | 2011 | https://conductscience.org/library/papers/21634011 | PubMed |
| 15 | 17671794 | Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia. | J Cancer Res Clin Oncol | 2007 | https://conductscience.org/library/papers/17671794 | PubMed |
| 16 | 19487300 | Adaptive therapy. | Cancer Res | 2009 | https://conductscience.org/library/papers/19487300 | PubMed |
| 17 | 10493507 | Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line. | Cancer Res | 1999 | https://conductscience.org/library/papers/10493507 | PubMed |
| 18 | 11904296 | Diphenyleneiodonium triggers the efflux of glutathione from cultured cells. | J Biol Chem | 2002 | https://conductscience.org/library/papers/11904296 | PubMed |
| 19 | 17549417 | Selected flavonoids potentiate the toxicity of cisplatin in human lung adenocarcinoma cells: a role for glutathione depletion. | Int J Oncol | 2007 | https://conductscience.org/library/papers/17549417 | PubMed |
| 20 | 22851001 | Dynamic ABCG2 expression in human embryonic stem cells provides the basis for stress response. | Eur Biophys J | 2013 | https://conductscience.org/library/papers/22851001 | PubMed |
Cited by79
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 174 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42797318 | Antitumor Efficacy of Apatinib and Etoposide-Loaded D-α-Tocopheryl Polyethylene Glycol Succinate Mixed Micelles Against Multidrug-Resistant Ovarian Cancer Cells. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42797318 | PubMed |
| 42218676 | Reframing cancer drug resistance: transporters, persister cells, senescence, and emerging therapeutic strategies. | Magy Onkol | 2026 | https://conductscience.org/library/papers/42218676 | PubMed |
| 41709507 | Phytochemical study of Homalanthus giganteus: isolation, antiproliferative activity, and computational mechanistic insights of tigliane diterpenes against colorectal cancer. | Pharm Biol | 2026 | https://conductscience.org/library/papers/41709507 | PubMed |
| 41585735 | A Comparative Study on the Iron and Copper Binding Properties of 8‑Hydroxyquinoline-Derived Mannich Bases Targeting Multidrug-Resistance Cancer Cells. | ACS Omega | 2026 | https://conductscience.org/library/papers/41585735 | PubMed |
| 41531982 | Improving Anticancer Activity of Doxorubicin by 4'-epi-Dehydroxyamination. | ACS Med Chem Lett | 2026 | https://conductscience.org/library/papers/41531982 | PubMed |
| 41471359 | Validation of a UPLC-MS/MS Method for Quantifying Intracellular Olaparib Levels in Resistant Ovarian Cancer Cells. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41471359 | PubMed |
| 40855238 | ABCC1 promotes GSH-dependent iron transport and resistance to Fe(II) and Cu(II) chelators. | Biometals | 2025 | https://conductscience.org/library/papers/40855238 | PubMed |
| 40786663 | Frequency-Dependent Ecological Interactions Increase the Prevalence, and Shape the Distribution, of Preexisting Drug Resistance. | PRX Life | 2024 | https://conductscience.org/library/papers/40786663 | PubMed |
| 39982595 | The impact of the ATP-binding cassette (ABC) transporter family on multidrug resistance in head and neck tumors. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/39982595 | PubMed |
| 39638428 | Organometallic Half-Sandwich Complexes of 8-Hydroxyquinoline-Derived Mannich Bases with Enhanced Solubility: Targeting Multidrug Resistant Cancer. | Inorg Chem | 2024 | https://conductscience.org/library/papers/39638428 | PubMed |
| 39093920 | Discovery of Potent Isoquinolinequinone N-Oxides to Overcome Cancer Multidrug Resistance. | J Med Chem | 2024 | https://conductscience.org/library/papers/39093920 | PubMed |
| 39064868 | Dual Inhibitors of P-gp and Carbonic Anhydrase XII (hCA XII) against Tumor Multidrug Resistance with Piperazine Scaffold. | Molecules | 2024 | https://conductscience.org/library/papers/39064868 | PubMed |
| 38771959 | Copper(II) Complexes with Isomeric Morpholine-Substituted 2-Formylpyridine Thiosemicarbazone Hybrids as Potential Anticancer Drugs Inhibiting Both Ribonucleotide Reductase and Tubulin Polymerization: The Morpholine Position Matters. | J Med Chem | 2024 | https://conductscience.org/library/papers/38771959 | PubMed |
| 38486992 | Metal nanoparticles for cancer therapy: Precision targeting of DNA damage. | Acta Pharm Sin B | 2024 | https://conductscience.org/library/papers/38486992 | PubMed |
| 38413011 | Drug resistance mechanisms in cancers: Execution of pro-survival strategies. | J Biomed Res | 2024 | https://conductscience.org/library/papers/38413011 | PubMed |
| 38204967 | Structural and molecular characterization of lopinavir and ivermectin as breast cancer resistance protein (BCRP/ABCG2) inhibitors. | EXCLI J | 2023 | https://conductscience.org/library/papers/38204967 | PubMed |
| 37616241 | Fighting Multidrug Resistance with Ruthenium-Cyclopentadienyl Compounds: Unveiling the Mechanism of P-gp Inhibition. | J Med Chem | 2023 | https://conductscience.org/library/papers/37616241 | PubMed |
| 37482017 | Metabolism-guided development of Ko143 analogs as ABCG2 inhibitors. | Eur J Med Chem | 2023 | https://conductscience.org/library/papers/37482017 | PubMed |
| 37108308 | ABCG2 in Acute Myeloid Leukemia: Old and New Perspectives. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37108308 | PubMed |
| 37063792 | An orthogonally activatable CRISPR-Cas13d nanoprodrug to reverse chemoresistance for enhanced chemo-photodynamic therapy. | Chem Sci | 2023 | https://conductscience.org/library/papers/37063792 | PubMed |
Genes25
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24758331
GET https://conductscience.org/api/papers/v1/24758331/references?page=2